Screener
BioLife Solutions BLFS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands, except per share and share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| IPR&D expense | — | 15,521 | — | 15,521 |
| Intangible asset amortization | 157 | 66 | 242 | 132 |
| Total operating expenses | 16,591 | 31,361 | 34,059 | 46,659 |
| Operating income (loss) | 1,696 | (16,126) | 1,725 | (16,624) |
| Other income: | ||||
| Interest income, net | 994 | 684 | 2,035 | 1,365 |
| Other income | 63 | 247 | 242 | 349 |
| Total other income, net | 1,057 | 931 | 2,277 | 1,714 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's operating income?
- BioLife Solutions (BLFS) reported operating income of $1.7M in Q2 2026.
- How has BioLife Solutions's operating income changed year-over-year?
- BioLife Solutions's operating income increased by 110.5% year-over-year, from -$16.13M to $1.7M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about BioLife Solutions's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude